𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant human erythropoietin: duplicate publication

✍ Scribed by Bradley A. Warady

Publisher
Springer
Year
1991
Tongue
English
Weight
90 KB
Volume
5
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recombinant human erythropoietin in pedi
Recombinant human erythropoietin in pediatric oncology: A review
✍ Feusner, James ;Hastings, Caroline πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract ## Background Numerous reports on recombinant human erythropoietin (rHuEPO, epoetin alfa) treatment of cancer‐related anemia in adult patients have been published to date. These have shown that epoetin increases hemoglobin levels, significantly ameliorates symptoms of anemia, and impro

Determination of recombinant human eryth
Determination of recombinant human erythropoietin by square wave voltammetry
✍ P. HernΓ‘ndez; O. Nieto; L. HernΓ‘ndez πŸ“‚ Article πŸ“… 1995 πŸ› Elsevier Science 🌐 English βš– 611 KB

The different variables that affect the determination of recombinant human erythropoietin (r-HuEPO) by square wave voltammetry are studied. The method is based on oxidation of mercury from the electrode surface and following the reduction wave of the mercury bound to the thiol groups from four cyste

Friedreich's ataxia: clinical pilot tria
Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin
✍ Sylvia Boesch; Brigitte Sturm; Sascha Hering; Hans Goldenberg; Werner Poewe; Bar πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

## Abstract To determine the role of recombinant human erythropoietin as a possible treatment option in Friedreich's ataxia, we performed an open‐label clinical pilot study. Primary outcome measure was the change of frataxin levels at week 8 versus baseline. Twelve Friedreich's ataxia patients rece